IDEAYA Biosciences IDYA

NASDAQ IDYA

$39.78 -0.19 (-0.48%)

As of: Sep 4, 2026 · 2:36 PM EDT

IDEAYA Biosciences (IDYA) Revenue Growth (5y) (2025 - 2026)

Analysis

IDEAYA Biosciences (IDYA) Revenue Growth (5y) (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	138.77 Bn	130.92 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.51 Bn	77.52 Bn	3.93 Bn
3	Argenx Se	63.51 Bn	58.32 Bn	1.37 Bn
4	Moderna	58.20 Bn	53.06 Bn	52.00 Mn
5	Revolution Medicines	44.04 Bn	44.04 Bn	-
6	BeOne Medicines	39.99 Bn	34.89 Bn	1.53 Bn
7	Alnylam Pharmaceuticals	35.45 Bn	32.14 Bn	992.69 Mn
8	Royalty Pharma	28.40 Bn	27.56 Bn	-
9	Insmed	27.44 Bn	26.28 Bn	358.27 Mn
10	IDEAYA Biosciences	3.66 Bn	2.83 Bn	-

Historic Data

Historic Data

Download Data

Date	Value
Jun 30, 2026	0.23%
Mar 31, 2026	-1.97%
Dec 31, 2025	0.57%
Sep 30, 2025	87.51%

IDEAYA Biosciences

NASDAQ: IDYA

$39.78 ▼ -0.19 (-0.48%)

Sep 4, 2026 · 2:36 PM EDT